Eris Lifesciences acquires Biocon Biologics’ branded formulation business for Rs 1,242cr
In a strategic move that reshapes the landscape of India’s injectables market, Eris Lifesciences Ltd., a leading player in the branded formulations sector, has announced the acquisition of Biocon Biologics’ India branded formulation business for a hefty sum of INR 1,242 crore. This acquisition not only signifies Eris Lifesciences’ aggressive entry into the burgeoning INR […]